Skip to content
City PM
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Opinion
  • DE
Tuesday 03 November 2015 12:06 pm

Cancer survival in London: A quarter die within two months following A&E diagnosis

By: Sarah Spickernell

Add as a preferred source on Google

Londoners diagnosed with cancer at accident and emergency departments have a very low chance of survival, new figures from Cancer Research UK show.

A quarter of people identified as having the disease at this late stage in hospitals across the capital die within two months, while the average survival is less than six months, the study found. Just 36 per cent live for more than a year.

The reason, according to the researchers, is that if cancer has gone this long without being detected, it means the disease has reached an advanced stage and is more likely to have spread to multiple parts of the body.

Read more: Scientists say immunotherapy could open a "new era" of cancer treatment

And when it reaches this level, not only are there fewer available options for treatment, but the effectiveness of any treatment is diminished.

The findings come from an analysis of 1,000 patients diagnosed with the disease at emergency units across London's 12 hospitals over the course of 2013.

Kathy Pritchard-Jones, author of the study, said this “hammers home” the need to focus on early diagnosis in the UK, as it can make a “huge difference to your chances of surviving cancer”.

Around a quarter of all cancer cases are being diagnosed following presentation in A&E and the vast majority of these are already at a late stage, when treatment options are limited and survival is poorer. And many of the patients diagnosed through A&E have other health conditions that may complicate their treatment.

We need to find ways to diagnose patients earlier, and through managed pathways. This is crucial to improving the UK's cancer survival to the standard of comparable countries.

Recognising the problem, the government is already taking steps to ensure cancer is caught earlier. In June this year, the National Institute for Health and Care Excellence (Nice), the government's health watchdog, put new guidelines in place that will “save thousands” of lives each year.

Nice is giving doctors in England basic diagnostic tests to help identify the disease in its early stages, so that patients can be referred to specialists before the symptoms become severe. GPs will have access to equipment such as CT scans and endoscopies, which are currently only available to specialists once referrals have gone ahead.

It is estimated that around 5,000 lives will be saved in England each year thanks to the earlier diagnosis that will result from this measure.

While the UK still lags behind many of its European neighbours in terms of cancer survival rates, overall the number of people getting the disease has gone down since the late 1990s. 

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Tech

Trending Articles

  • Citroën 2CV returns as a £13,000 electric car, and the timing is no accident

  • James Watt offers to buy back Brewdog

  • Bank of England warns Burnham of UK economy’s ‘big issue’

  • The former African gold miner taking on the billionaire Issa brothers

  • Rachel Reeves to unveil next steps for ring-fencing reform at Mansion House

More from City PM

  • Anocca has Dosed First Patients with Precision TCR-T Cell Therapy Targeting Mutant KRAS in Pancreatic Cancer

    Business Wire
  • GSK shares slip after buying US cancer treatment firm Nuvalent for $10.6bn

    Pharma
    GSK logo displayed prominently, signifying the companys presence and relevance in the business and healthcare sectors.
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Araris Biotech AG and Taiho Oncology Announce Dosing of First Patient in Phase 1 Trial of ARC-02, a Novel ADC for the Treatment of Non-Hodgkin Lymphoma

    Business Wire
  • People named Mark called upon to raise money at London charity golf day

    Sport Business
    Breaking news concept with digital globe and newspaper headlines on a blue background, representing global journalism.
  • Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

    Healthcare
    Hikma produces generic drugs
  • IMU Biosciences Selects Waters to Advance Breakthrough AI Immune Mapping Platform to Transform Early Diagnosis, Monitoring, and Precision Medicine

    Business Wire
  • Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera

    Business Wire

City PM — European politics, business and analysis.

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Topics

  • Business
  • Markets
  • AI
  • Technology
  • Opinion
  • Energy

More

  • Politics
  • Economics
  • Fintech
  • Legal
  • Sport
  • Life

Company

  • About City PM
  • Editorial Policy
  • Corrections
  • Contact
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
© 2026 City PM · Published by CityPM Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
About · Editorial Policy · Corrections · Contact · Privacy · Facebook